Case Series
Cryptococcal Meningitis in Post-COVID Era: A Case Series
Correspondence Address :
Dr. Antara Roy,
Ramnagar 1st lane, Akhaura Road, Agartala-799002, Tripura West, Tripura, India.
E-mail: royantara63@gmail.com
Meningitis, defined as inflammation of the meninges surrounding the brain and spinal cord, can arise from a broad spectrum of infectious and non infectious causes. Among infectious aetiologies, fungal meningitis is less common but poses significant morbidity and mortality. Cryptococcal meningitis, a life-threatening fungal infection primarily affecting immunocompromised individuals, has shown an increased incidence in the post-Coronavirus Disease-2019 (COVID-19) era. Immune dysregulation caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and the widespread use of immunosuppressive therapies are suspected contributors to this rise. The first case was a 47-year-old Human Immunodeficiency Virus (HIV)-positive man on tuberculosis treatment who presented with meningitis symptoms; India ink preparation showed a yeast cell with a refractile halo. The second case was a 75-year-old man with a prior COVID-19 infection who developed meningitis and was diagnosed with cryptococcal meningitis. The third case was a 37-year-old asthmatic female on steroids with a history of COVID-19 who presented with headache and altered sensorium. Cerebrospinal Fluid (CSF) was collected and sent for investigation. India ink showed encapsulated yeast cells and culture showed Gram-positive budding yeast cells. The fourth case was a 50-year-old male with chronic kidney disease who presented with fever, neck stiffness and altered sensorium. Gram stain of CSF and India ink preparation both showed Cryptococcus. All patients were treated with amphotericin B and fluconazole, with favourable clinical outcomes. Clinicians should maintain a high index of suspicion for opportunistic fungal infections in patients with recent COVID-19 or immunosuppressive therapy.
Cryptococcus, Fungal infections, Immunocompromised
DOI: 10.7860/JCDR/2025/80970.21880
Date of Submission: May 30, 2025
Date of Peer Review: Jun 20, 2025
Date of Acceptance: Aug 18, 2025
Date of Publishing: Oct 01, 2025
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jun 06, 2025
• Manual Googling: Aug 14, 2025
• iThenticate Software: Aug 16, 2025 (6%)
ETYMOLOGY: Author Origin
EMENDATIONS: 8
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase
- EBSCOhost
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)
- www.omnimedicalsearch.com
